FDA Approves Mimrylo, a First-in-Class Drug for Polycythemia Vera

THURSDAY, Sept. 3, 2026 -- The U.S. Food and Drug Administration has approved Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
Mimrylo mimics hepcidin, a...